These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
196 related articles for article (PubMed ID: 32708987)
21. Molecular recognition of curcumin (Indian Ayurvedic medicine) by the supramolecular probe, p-t-butyl calix(8)arene. Meenakshi C; Jayabal P; Ramakrishnan V Spectrochim Acta A Mol Biomol Spectrosc; 2014 Jun; 127():172-6. PubMed ID: 24632170 [TBL] [Abstract][Full Text] [Related]
22. Transdermal delivery of curcumin-loaded supramolecular hydrogels for dermatitis treatment. Zhou F; Song Z; Wen Y; Xu H; Zhu L; Feng R J Mater Sci Mater Med; 2019 Jan; 30(1):11. PubMed ID: 30617652 [TBL] [Abstract][Full Text] [Related]
23. Dithranol-loaded nanostructured lipid carrier-based gel ameliorate psoriasis in imiquimod-induced mice psoriatic plaque model. Sathe P; Saka R; Kommineni N; Raza K; Khan W Drug Dev Ind Pharm; 2019 May; 45(5):826-838. PubMed ID: 30764674 [TBL] [Abstract][Full Text] [Related]
24. Skin targeting of curcumin solid lipid nanoparticles-engrossed topical gel for the treatment of pigmentation and irritant contact dermatitis. Shrotriya S; Ranpise N; Satpute P; Vidhate B Artif Cells Nanomed Biotechnol; 2018 Nov; 46(7):1471-1482. PubMed ID: 28884598 [TBL] [Abstract][Full Text] [Related]
25. Psoralen loaded liposomal nanocarriers for improved skin penetration and efficacy of topical PUVA in psoriasis. Doppalapudi S; Jain A; Chopra DK; Khan W Eur J Pharm Sci; 2017 Jan; 96():515-529. PubMed ID: 27777066 [TBL] [Abstract][Full Text] [Related]
26. Design and evaluation of transdermal drug delivery system for curcumin as an anti-inflammatory drug. Patel NA; Patel NJ; Patel RP Drug Dev Ind Pharm; 2009 Feb; 35(2):234-42. PubMed ID: 18785045 [TBL] [Abstract][Full Text] [Related]
27. Topical administration of nanocarrier miRNA-210 antisense ameliorates imiquimod-induced psoriasis-like dermatitis in mice. Feng H; Wu R; Zhang S; Kong Y; Liu Z; Wu H; Wang H; Su Y; Zhao M; Lu Q J Dermatol; 2020 Feb; 47(2):147-154. PubMed ID: 31773789 [TBL] [Abstract][Full Text] [Related]
28. Dang-Gui-Liu-Huang Tang a traditional herbal formula, ameliorates imiquimod-induced psoriasis-like skin inflammation in mice by inhibiting IL-22 production. Nguyen LTH; Ahn SH; Nguyen UT; Yang IJ Phytomedicine; 2018 Aug; 47():48-57. PubMed ID: 30166108 [TBL] [Abstract][Full Text] [Related]
29. Augmented Transdermal Delivery of Curcumin for the Effective Management of Plaque Psoriasis - Design, Formulation, Characterisation, and In Vivo Studies. Kumar B; Sahoo PK AAPS PharmSciTech; 2023 Jun; 24(5):134. PubMed ID: 37291356 [TBL] [Abstract][Full Text] [Related]
30. Enhanced transdermal efficiency of curcumin-loaded peptide-modified liposomes for highly effective antipsoriatic therapy. Yu F; Zhang Y; Yang C; Li F; Qiu B; Ding W J Mater Chem B; 2021 Jun; 9(24):4846-4856. PubMed ID: 34047333 [TBL] [Abstract][Full Text] [Related]
31. Improved topical delivery of tacrolimus: A novel composite hydrogel formulation for the treatment of psoriasis. Gabriel D; Mugnier T; Courthion H; Kranidioti K; Karagianni N; Denis MC; Lapteva M; Kalia Y; Möller M; Gurny R J Control Release; 2016 Nov; 242():16-24. PubMed ID: 27639683 [TBL] [Abstract][Full Text] [Related]
32. Self-inclusion of proline-functionalised calix[4]arene leads to hydrogelation. Goh CY; Becker T; Brown DH; Skelton BW; Jones F; Mocerino M; Ogden MI Chem Commun (Camb); 2011 Jun; 47(21):6057-9. PubMed ID: 21512712 [TBL] [Abstract][Full Text] [Related]
33. Percutaneous delivery of α-melanocyte-stimulating hormone for the treatment of imiquimod-induced psoriasis. Shah PP; Desai PR; Boakye CH; Patlolla R; Kikwai LC; Babu RJ; Singh M J Drug Target; 2016; 24(6):537-47. PubMed ID: 26582563 [TBL] [Abstract][Full Text] [Related]
34. Facile fabrication of bowl-shaped microparticles for oral curcumin delivery to ulcerative colitis tissue. Chen Q; Gou S; Huang Y; Zhou X; Li Q; Han MK; Kang Y; Xiao B Colloids Surf B Biointerfaces; 2018 Sep; 169():92-98. PubMed ID: 29751345 [TBL] [Abstract][Full Text] [Related]
35. Effect of γ-secretase inhibitor on Th17 cell differentiation and function of mouse psoriasis-like skin inflammation. Ma L; Xue H; Qi R; Wang Y; Yuan L J Transl Med; 2018 Mar; 16(1):59. PubMed ID: 29523162 [TBL] [Abstract][Full Text] [Related]
36. Fenoldopam mesylate for treating psoriasis: A new indication for an old drug. Doppalapudi S; Jain A; Khan W; Domb AJ Int J Pharm; 2020 Jan; 573():118726. PubMed ID: 31715365 [TBL] [Abstract][Full Text] [Related]
37. An Intestinal "Transformers"-like Nanocarrier System for Enhancing the Oral Bioavailability of Poorly Water-Soluble Drugs. Chuang EY; Lin KJ; Huang TY; Chen HL; Miao YB; Lin PY; Chen CT; Juang JH; Sung HW ACS Nano; 2018 Jul; 12(7):6389-6397. PubMed ID: 29856923 [TBL] [Abstract][Full Text] [Related]
38. Effect of carboxylic acid on micelles of a neutral amphiphilic dendro-calix[4]arene. Huang H; Li DM; Wang W; Chen YC; Khan K; Song S; Zheng YS Org Biomol Chem; 2012 Jan; 10(4):729-35. PubMed ID: 22130612 [TBL] [Abstract][Full Text] [Related]
39. Hyaluronic acid-based supramolecular medicine with polyamines sequestration capability for cooperative anti-psoriasis. Ding YF; Wei J; Quan X; Gu W; Xi L; Zheng Y; Zhao Y; Luo J; Li S; Mok GSP; Wang R Carbohydr Polym; 2022 Nov; 296():119968. PubMed ID: 36088007 [TBL] [Abstract][Full Text] [Related]
40. A supramolecular nanoprodrug based on a boronate ester linked curcumin complexing with water-soluble pillar[5]arene for synergistic chemotherapies. Chao S; Lv X; Ma N; Shen Z; Zhang F; Pei Y; Pei Z Chem Commun (Camb); 2020 Aug; 56(62):8861-8864. PubMed ID: 32638757 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]